SEC Comment Letter for InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — May 20, 2020
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: May 20, 2020 · CIK: 0001433607 · Accession: 0000000000-20-004486
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-238247
Letter
United States securities and exchange commission logo May 19, 2020 Marvin Slosman Chief Executive Officer InspireMD, Inc. 4 Menorat Hamaor St. Tel Aviv, Israel 6744832 Re:InspireMD, Inc. Registration Statement on Form S-1 Filed May 13, 2020 File No. 333-238247 Dear Mr. Slosman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at (202) 551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David Glatt, Meitar
Show Raw Text
United States securities and exchange commission logo
May 19, 2020
Marvin Slosman
Chief Executive Officer
InspireMD, Inc.
4 Menorat Hamaor St.
Tel Aviv, Israel 6744832
Re:InspireMD, Inc.
Registration Statement on Form S-1
Filed May 13, 2020
File No. 333-238247
Dear Mr. Slosman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at (202) 551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: David Glatt, Meitar